Publication | Closed Access

Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial

OncologyPathologyBronchial NeoplasmCancer TreatmentCancer GeneticsMedicineRadiation OncologyLung Cancer